'Stage ii' presentation slideshows

1.14k views • 81 slides

Safe Sedation for patients with special needs

Safe Sedation for patients with special needs. Dr John M LOW MA. (Oxford University) BM.BCh . (Oxford University) FRCA. , FHKCA. , FANZCA., FHKAM .( Anaesthesiology ) Partner, Dr. Roger Hung and Partners. Overview. Achieving sympatholysis Sedation vs General Anaesthesia

949 views • 81 slides

Adjuvante therapie van het coloncarcinoom anno 2004-2005: is 5FU/LV nog steeds de standaard?

Adjuvante therapie van het coloncarcinoom anno 2004-2005: is 5FU/LV nog steeds de standaard?. Prof.dr. C.J.A. Punt afd. Medische Oncologie UMC St. Radboud Nijmegen. Adjuvant therapy for colon cancer hot topics 2004. FOLFOX Capecitabine Stage II Primary endpoint in randomised studies.

616 views • 51 slides

856 views • 47 slides

More approximation algorithms for stochastic programming programs

679 views • 46 slides

Recent progress of the KISS project at KEK-WNSC

497 views • 43 slides

Axel Grothey Professor of Oncology Mayo Clinic, Rochester, Minnesota, USA

Axel Grothey Professor of Oncology Mayo Clinic, Rochester, Minnesota, USA. Vice Chair and Director of Cancer Treatment of the North Central Cancer Treatment Group (NCCTG) Co-chair of the gastrointestinal program of NCCTG

569 views • 43 slides

Prof Sanjay Patole, MD, DCH, FRACP, MSc, DrPH Centre for Neonatal Research and Education

Ad vances in necrotising enterocolitis. Prof Sanjay Patole, MD, DCH, FRACP, MSc, DrPH Centre for Neonatal Research and Education KEM Hospital for Women, University of Western Australia, Perth. Necrotising enterocolitis in preterm neonates.

1.2k views • 39 slides

FRIENDSHIP

420 views • 39 slides

an Endcap TOF and TRD for Identifying electrons at EIC

an Endcap TOF and TRD for Identifying electrons at EIC.

322 views • 24 slides

Adjuvant therapy for stage II colon cancer: where are we now?

Adjuvant therapy for stage II colon cancer: where are we now?. Professor Werner Scheithauer University of Vienna Vienna, Austria. Healthcare providers. Treatment costs. Resource use. Factors that may influence adjuvant treatment decisions. Patient characteristics. Biomarkers.

548 views • 21 slides

New Zealand National Poisons Centre

New Zealand National Poisons Centre. IRON OVERDOSE. IRON. In healthy adults ~ 2 to 10% of dietary iron absorbed In iron deficiency states (including children) 80 to 90% is absorbed

316 views • 20 slides

Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR)

7B.7 Inter-comparison of AFWA Operational Configurations using WRFv3.3.1 and WRFv3.4. Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR) Research Applications Laboratory (RAL) and Developmental Testbed Center (DTC). AFWA Configuration Testing.

307 views • 19 slides

Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR)

7B.7 Inter-comparison of AFWA Operational Configurations using WRFv3.3.1 and WRFv3.4. Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR) Research Applications Laboratory (RAL) and Developmental Testbed Center (DTC). AFWA Configuration Testing.

323 views • 19 slides

Management of Vulval Cancer Services in South West England

Management of Vulval Cancer Services in South West England. Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour Panel. September 2004. SWIS Gynaecology Tumour Panel. 4 Cancer Networks. Multidisciplinary membership. 3 Counties. ASWCS.

1.07k views • 18 slides

Kidney Cancer Treatment

Kidney Cancer Treatment

227 views • 10 slides

208 views • 7 slides

Fatigue striation morphology

385 views • 6 slides

118 views • 4 slides

Gene cluster

Gene cluster. 1. 2. 3. Stage I. Stage II. Stage III/IV. A549. NCI-H460, EKVX, HOP-92, NCI-H226, HOP-62.

103 views • 1 slides